Strategic Acquisition CareZone was acquired by Walmart in 2020 and its technology platform, patents, and key intellectual property were folded into Walmart’s ecosystem. This signals strong enterprise-grade capabilities and potential for cross‑selling or integration opportunities with Walmart’s vast health and retail network.

Platform Capabilities The core offering enables patients to manage medications and health information from mobile devices, suggesting upsell potential to health plans, pharmacies, and employer wellness programs seeking streamlined medication management and patient data portability.

Financial Position Reported revenue in the low single to mid single digits with substantial funding history (funding around 168M) and recent IP and asset acquisition by Walmart, indicating a shift toward integration with a larger corporate platform and potential for channel partnerships via Walmart’s ecosystems.

Operational Footprint Small to mid-sized team (11-50 employees) with dual US offices (San Francisco and Seattle), presenting an agile partner profile attractive for pilot programs, co-development, or regional healthcare initiatives within West Coast markets.

Competitive Positioning In a landscape with large players and health tech platforms, CareZone’s assets focus on patient-organized prescription information and medication management, creating an entry point for B2B collaborations with pharmacies, PBMs, and digital health retailers seeking to enhance patient medication adherence and data accuracy.